Anthony DiGiandomenico - 01 Oct 2026 Form 4 Insider Report for EXOZYMES INC. (EXOZ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Oct 2026, 19:47:15 UTC
Prior SEC filing
02 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anthony DiGiandomenico
Filing notes and source

Key filing fact

Anthony DiGiandomenico filed Form 4 for EXOZYMES INC. (EXOZ) on 19 Oct 2026.

Key facts

  • This page summarizes Anthony DiGiandomenico's Form 4 filing for EXOZYMES INC. (EXOZ).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 19 Oct 2026, 19:47.

Change

  • Previous filing in this sequence was filed on 02 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001083544 Primary reporting owner

DIGIANDOMENICO ANTHONY

Relationship
Director, 10%+ Owner
Address
C/O 14133 MIDWAY ROAD, SUITE G-150, ADDISON
Signature
/s/ Anthony DiGiandomenico
Signature date
19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXOZ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,808,476
Date
01 Oct 2026
Ownership
See Footnote
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXOZ transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+10,000
Change %
Price
$0.000000*
Shares after
10,000
Date
01 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$6.28
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option vests in twelve (12) quarterly installments, consisting of eleven (11) installments of 833 shares and a final installment of 837 shares, beginning on 12/31/2026 and ending on 09/30/2029, subject to the reporting person's continued service with the issuer. The option expires on 10/01/2033.

Footnote F2

Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .